Discovering Novel Tumor-Reactive Antibodies in Pembrolizumab-Treated NSCLC
Research Grant
Administered By
Medicine, Medical Oncology
Awarded By
Lung Cancer Initiative of North Carolina
Start Date
January 1, 2023
End Date
December 31, 2023
Administered By
Medicine, Medical Oncology
Awarded By
Lung Cancer Initiative of North Carolina
Start Date
January 1, 2023
End Date
December 31, 2023